| P50 | author | Steven Rosenberg | Q2347448 |
| | Nicholas P. Restifo | Q51142479 |
| | Christopher A. Klebanoff | Q55999011 |
| | Robert B. Nussenblatt | Q83234942 |
| | Luca Gattinoni | Q85315718 |
| | Christian S Hinrichs | Q96093610 |
| | Chrystal M Paulos | Q96306368 |
| | Claudia Wrzesinski | Q114521243 |
| | Douglas Palmer | Q42598676 |
| P2093 | author name string | Daniel J Powell | |
| | Chi-Chao Chan | |
| | Robert N Fariss | |
| | Zhiya Yu | |
| | Steven E Finkelstein | |
| P2860 | cites work | Five new human cancer‐germline genes identified among 12 genes expressed in spermatogonia | Q44409599 |
| | Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma | Q45287769 |
| | Lasker Basic Medical Research Award. Dendritic cells: versatile controllers of the immune system | Q48327526 |
| | Melanocyte lysis by cytotoxic T lymphocytes recognizing the MART-1 melanoma antigen in HLA-A2 patients with Vogt-Koyanagi-Harada disease. | Q55240558 |
| | TCR affinity and negative regulation limit autoimmunity | Q57184989 |
| | Vitiligo in patients with melanoma: normal tissue antigens can be targets for cancer immunotherapy | Q71659964 |
| | T cell immune responses against melanoma and melanocytes in cancer and autoimmunity | Q73101262 |
| | Dendritic cell targeting of survivin protein in a xenogeneic form elicits strong CD4+ T cell immunity to mouse survivin | Q79401063 |
| | Integrative genomic analysis of phosphatidylinositol 3'-kinase family identifies PIK3R3 as a potential therapeutic target in epithelial ovarian cancer | Q81310317 |
| | Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells | Q24540135 |
| | Adoptive immunotherapy for cancer: building on success | Q24546258 |
| | Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma | Q24548019 |
| | Cancer immunotherapy: moving beyond current vaccines | Q24548229 |
| | A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening | Q24564781 |
| | Cancer regression in patients after transfer of genetically engineered lymphocytes | Q24654976 |
| | Identification of human cancers deficient in antigen processing | Q24678495 |
| | Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues | Q28188712 |
| | Tolerogenic dendritic cells | Q29618755 |
| | Integrating epitope data into the emerging web of biomedical knowledge resources | Q31111568 |
| | Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies | Q33912061 |
| | Ocular immune privilege: therapeutic opportunities from an experiment of nature | Q34282825 |
| | Making room for T cells | Q34744971 |
| | Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes. | Q35064131 |
| | Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling. | Q35901034 |
| | Cytokines in cancer immunity and immunotherapy | Q35951855 |
| | Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma | Q36119828 |
| | TNF-alpha is critical for antitumor but not antiviral T cell immunity in mice | Q36121743 |
| | Immunotherapy for gynaecological malignancies. | Q36239661 |
| | Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo. | Q36368332 |
| | Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells. | Q36371632 |
| | gp100/pmel 17 is a murine tumor rejection antigen: induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligand | Q36401461 |
| | Human T cell responses against melanoma | Q36427328 |
| | Vaccine-stimulated, adoptively transferred CD8+ T cells traffic indiscriminately and ubiquitously while mediating specific tumor destruction. | Q36456749 |
| | Identification of T-cell epitopes for cancer immunotherapy | Q36870592 |
| | A MAGE-1 antigenic peptide recognized by human cytolytic T lymphocytes on HLA-A2 tumor cells | Q40396489 |
| | The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes | Q41411510 |
| | Contrasting frequencies of antitumor and anti-vaccine T cells in metastases of a melanoma patient vaccinated with a MAGE tumor antigen | Q41870799 |
| P433 | issue | 23 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 8061-8066 | |
| P577 | publication date | 2008-06-03 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Effective tumor treatment targeting a melanoma/melanocyte-associated antigen triggers severe ocular autoimmunity | |
| P478 | volume | 105 | |